[ACS] Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers |
Reward10points
|
| |
| |
10
On-Demand and Efficient Fabrication of Sub-10 nm Solid-State Nanopore Arrays
10
Pressure-Induced Schottky-Ohmic Contact Transition in Pt/Si Heterojunction Via Interfacial Barrier Modulation for Ultra-Enhanced Photocurrent Generation
10
Radical Sampling Enabled Saturated N-Heterocycle Cyclization
10
Exploring the Frontier: Plant-Based Coatings Innovations
10
Current Progress on Nanomaterials for Direct Optical Sensing of Organophosphorus Pesticides